CU Anschutz Clinical Trial Shows Fewer Heavy Drinking Days PR Newswire AURORA, Colo., July 29, 2026 A study from the University of Colorado Anschutz found that the popular diabetes and weight loss drug reduced heavy drinking and alcohol-related harm in adults with Alcohol Use Disorder AURORA, Colo., July 29, 2026 /PRNewswire/ -- A clinical trial led by researchers at CU Anschutz has found that oral semaglutide, a medication widely used for diabetes and weight loss, reduces heavy drinking in adults with Alcohol Use Disorder (AUD)
Cane sugar (sucrose) wont work to treat your hypoglycemia while youre taking acarbose
Typical dosing ranges for BPC-157 in animal studies vary per the specific models used
FAQs: Retatrutide Side Effects What are the benefits of retatrutide
BPC-157 resists enzymatic breakdown which is precisely why oral delivery is a meaningful research variable for this compound, not a theoretical one.2 But that stability does not mean every delivery route produces the same result